X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
0
https://www.globenewswire.com/news-release/2021/12/10/2350025/37568/en/Merus-Presents-Updated-Analysis-of-Zenocutuzumab-Trastuzumab-and-Vinorelbine-in-Patients-with-HER2-Metastatic-Breast-Cancer-at-the-San-Antonio-Breast-Cancer-Symposium.html
https://www.openpr.com/news/1988743/vinorelbine-market-in-depth-study-on-industry-size
https://www.biospectrumasia.com/news/25/14766/tlc-announces-completion-of-27-m-financing.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208997
https://www.pharmacompass.com/pdf/news/jiangsu-yew-pharmaceutical-co-ltd-fails-edqm-inspection-1537438043.pdf
https://www.pharmacompass.com/pdf/news/five-drugs-suspended-after-factory-inspection-1509081498.pdf
https://www.medicalnewsbulletin.com/treating-metastatic-breast-cancer-olaparib/
https://mesotheliomaresearchnews.com/2017/07/26/trial-shows-anetumab-ravtansine-is-unable-to-top-vinorelbine-as-a-mesothelioma-therapy/
https://www.europeanpharmaceuticalreview.com/48558/news/industry-news/astrazeneca-phase-iii-breast-cancer/
https://www.pharmacompass.com/pdf/news/zhejiang-hisun-pharmaceutical-co-ltd-yantou-campus-fails-edqm-inspection-1483966941.pdf
Market Place
Share 
